Hans Gühring

1.5k total citations
32 papers, 1.3k citations indexed

About

Hans Gühring is a scholar working on Pharmacology, Physiology and Molecular Biology. According to data from OpenAlex, Hans Gühring has authored 32 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 9 papers in Physiology and 8 papers in Molecular Biology. Recurrent topics in Hans Gühring's work include Pain Mechanisms and Treatments (9 papers), Inflammatory mediators and NSAID effects (8 papers) and Osteoarthritis Treatment and Mechanisms (6 papers). Hans Gühring is often cited by papers focused on Pain Mechanisms and Treatments (9 papers), Inflammatory mediators and NSAID effects (8 papers) and Osteoarthritis Treatment and Mechanisms (6 papers). Hans Gühring collaborates with scholars based in Germany, United States and Switzerland. Hans Gühring's co-authors include Kay Brune, Mehmet Ateş, Gerd Geißlinger, Irmgard Tegeder, Hanns Ulrich Zeilhofer, May Hamza, Andreas Pahl, Ellen Niederberger, Catherine Ledent and M. Michaelis and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Neuroscience and The FASEB Journal.

In The Last Decade

Hans Gühring

30 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans Gühring Germany 18 550 439 428 325 104 32 1.3k
Carlos Rogério Tonussi Brazil 18 157 0.3× 586 1.3× 229 0.5× 283 0.9× 73 0.7× 42 1.0k
Larissa G. Pinto Brazil 22 130 0.2× 349 0.8× 354 0.8× 165 0.5× 154 1.5× 38 1.3k
Sipra Saha Sweden 10 724 1.3× 195 0.4× 405 0.9× 141 0.4× 58 0.6× 13 1.5k
Vanessa Pacciari Gutierrez Brazil 14 171 0.3× 440 1.0× 624 1.5× 208 0.6× 22 0.2× 23 1.5k
Ieda R. S. Schivo Brazil 9 106 0.2× 452 1.0× 256 0.6× 231 0.7× 42 0.4× 9 871
Isabel Carreras United States 24 291 0.5× 678 1.5× 808 1.9× 259 0.8× 33 0.3× 43 1.9k
Sérgio Henrique Ferreira Brazil 14 117 0.2× 524 1.2× 263 0.6× 244 0.8× 36 0.3× 17 1.0k
Kohichi Kawahara Japan 16 167 0.3× 346 0.8× 443 1.0× 190 0.6× 26 0.3× 36 1.2k
Hae Sook Noh South Korea 22 170 0.3× 422 1.0× 612 1.4× 174 0.5× 31 0.3× 40 1.4k
Milind M. Muley Canada 14 144 0.3× 341 0.8× 291 0.7× 197 0.6× 79 0.8× 17 881

Countries citing papers authored by Hans Gühring

Since Specialization
Citations

This map shows the geographic impact of Hans Gühring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Gühring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Gühring more than expected).

Fields of papers citing papers by Hans Gühring

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Gühring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Gühring. The network helps show where Hans Gühring may publish in the future.

Co-authorship network of co-authors of Hans Gühring

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Gühring. A scholar is included among the top collaborators of Hans Gühring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Gühring. Hans Gühring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bar‐Or, Amit, Anne H. Cross, Anthony L. Cunningham, et al.. (2023). Antibody response to SARS-CoV-2 vaccines in patients with relapsing multiple sclerosis treated with evobrutinib: A Bruton’s tyrosine kinase inhibitor. Multiple Sclerosis Journal. 29(11-12). 1471–1481. 4 indexed citations
2.
Gigout, Anne, Christian Brenneis, Frances Henson, et al.. (2022). R399E, A Mutated Form of Growth and Differentiation Factor 5, for Disease Modification of Osteoarthritis. Arthritis & Rheumatology. 75(3). 375–386. 3 indexed citations
3.
Barratt, Jonathan, James A. Tumlin, Yusuke Suzuki, et al.. (2022). Randomized Phase II JANUS Study of Atacicept in Patients With IgA Nephropathy and Persistent Proteinuria. Kidney International Reports. 7(8). 1831–1841. 67 indexed citations
4.
Michaelis, M., et al.. (2020). Importance of Osmolarity and Oxygen Tension for Cartilage Tissue Engineering. BioResearch open access. 9(1). 106–115. 20 indexed citations
5.
Brett, Alan, M.A. Bowes, Philip G. Conaghan, et al.. (2019). SAT0647 MRI DATA FROM THE SPRIFERMIN PHASE II FORWARD STUDY: CONFIRMATION OF MANUAL CARTILAGE SEGMENTATION FINDINGS BY AUTOMATED SEGMENTATION. Annals of the Rheumatic Diseases. 78. 1421–1423. 2 indexed citations
6.
Bihlet, Asger Reinstrup, M.A. Karsdal, I. Byrjalsen, et al.. (2016). OP0092 Identification of Pain Subtypes Associated with Placebo-Response: Data from Two Phase 3 Randomized Clinical Trials in Symptomatic Knee Osteoarthritis. Annals of the Rheumatic Diseases. 75. 89–90. 1 indexed citations
7.
Meindl, K., Timo Schmiederer, Kathrin Schneider, et al.. (2010). Labyrinthopeptine – eine neue Klasse carbacyclischer Lantibiotika. Angewandte Chemie. 122(6). 1169–1173. 26 indexed citations
8.
Meindl, K., Timo Schmiederer, Kathrin Schneider, et al.. (2010). Labyrinthopeptins: A New Class of Carbacyclic Lantibiotics. Angewandte Chemie International Edition. 49(6). 1151–1154. 177 indexed citations
9.
Ateş, Mehmet, et al.. (2003). Intrathecally applied flurbiprofen produces an endocannabinoid‐dependent antinociception in the rat formalin test. European Journal of Neuroscience. 17(3). 597–604. 65 indexed citations
10.
11.
Gühring, Hans, May Hamza, Marina Sergejeva, et al.. (2002). A role for endocannabinoids in indomethacin-induced spinal antinociception. European Journal of Pharmacology. 454(2-3). 153–163. 108 indexed citations
12.
13.
Gühring, Hans, et al.. (2001). HU-210 shows higher efficacy and potency than morphine after intrathecal administration in the mouse formalin test. European Journal of Pharmacology. 429(1-3). 127–134. 27 indexed citations
14.
Gühring, Hans, Irmgard Tegeder, Jörn Lötsch, et al.. (2001). Role of nitric oxide in zymosan induced paw inflammation and thermal hyperalgesia. Inflammation Research. 50(2). 83–88. 47 indexed citations
15.
Tegeder, Irmgard, Ellen Niederberger, Hans Gühring, et al.. (2001). Inhibition of NF‐ κ B and AP‐1 activation by R‐ and S‐flurbiprofen 1 2. The FASEB Journal. 15(3). 595–597. 119 indexed citations
16.
17.
Tegeder, Irmgard, W. M. Neupert, Hans Gühring, & Gerd Geißlinger. (2000). Effects of Selective and Unselective Cyclooxygenase Inhibitors on Prostanoid Release from Various Rat Organs. Journal of Pharmacology and Experimental Therapeutics. 292(3). 1161–1168. 42 indexed citations
18.
Zeilhofer, Hanns Ulrich, et al.. (2000). Selective Suppression of Inhibitory Synaptic Transmission by Nocistatin in the Rat Spinal Cord Dorsal Horn. Journal of Neuroscience. 20(13). 4922–4929. 68 indexed citations
19.
Gühring, Hans, et al.. (1996). Muscle Damping Measured With a Modified Pendulum Test in Patients With Fibromyalgia, Lumbago, and Cervical Syndrome. Spine. 21(18). 2137–2142. 18 indexed citations
20.
Gühring, Hans. (1992). [Comments on a letter].. PubMed. 60(4-5). 150–150. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carlos Rogério Tonussi Breakdown of academic impact, for papers by Larissa G. Pinto Breakdown of academic impact, for papers by Sipra Saha Breakdown of academic impact, for papers by Vanessa Pacciari Gutierrez Breakdown of academic impact, for papers by Ieda R. S. Schivo Breakdown of academic impact, for papers by Isabel Carreras Breakdown of academic impact, for papers by Sérgio Henrique Ferreira Breakdown of academic impact, for papers by Kohichi Kawahara Breakdown of academic impact, for papers by Hae Sook Noh Breakdown of academic impact, for papers by Milind M. Muley
Rankless by CCL
2026